METTL1 and head and neck squamous cell carcinoma: Meanwhile, it was shown that the phosphorylation of the PI3K/AKT/mTOR pathway mediated by METTL1 is necessary for the development of HNSCC, and targeting METTL1 will become an important therapeutic target in the future.